Evidence map›Paper›PMID 42506672›Full record

ArticleVaccines2026

A Multi-State, Cross-Sectional Retrospective Study on Knowledge, Attitude and Practice of Rabies Post-Exposure Prophylaxis Including Rabies Monoclonal Antibody Among Physicians Across India.

Ravish Haradanahalli Shankaraiah, Navyashree N S, Divya Bharathi G, Trayambak Dutta, Manish Mahajan

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ravish Haradanahalli ShankaraiahDepartment of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore 560070, India.
Navyashree N SDepartment of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore 560070, India.
Divya Bharathi GDepartment of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore 560070, India.
Trayambak DuttaVaccines, Zydus Life Sciences Ltd., Ahmedabad 382481, India.ORCID 0000-0001-9643-9509
Manish MahajanBiologics & Vaccines, Zydus Lifesciences Ltd., Ahmedabad 382481, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesRabies remains a lethal vaccine-preventable disease in India, and physicians managing animal-bite cases are central to effective post-exposure prophylaxis (PEP). With the increasing use of rabies monoclonal antibodies (RmAbs) as alternatives to conventional rabies immunoglobulins, this study assessed physicians' knowledge, attitude, and practice (KAP) regarding rabies PEP, including RmAb awareness and acceptance.

methodsThis multi-state, cross-sectional retrospective KAP survey was conducted among 208 physicians across ten Indian states using a structured, self-administered Google Form. The 33-item questionnaire assessed Knowledge, Attitude, and Practice domains, with 11 items each, scored binarily according to NCDC guidelines. Descriptive statistics, Shapiro-Wilk normality testing, Kruskal-Wallis tests with post hoc corrections, and Spearman rank-order correlations were performed.

resultsMean domain scores were 8.00/11 for Knowledge (72.7%), 7.22/11 for Attitude (65.6%), and 8.64/11 for Practice (78.5%). Key gaps were identified in the intramuscular pre-exposure prophylaxis schedule, management of excess RIG/RmAb after wound infiltration, exposure categorization of animal contact, and vaccine administration site in young children. The Knowledge-Practice correlation was moderately strong and statistically significant (r = 0.520,

conclusionsOverall KAP scores were adequate, with Practice scoring highest. Targeted continuing medical education focused on NCDC guidelines and practical PEP scenarios is needed among physicians managing rabies exposures.

Indexed as

KAPphysicianspost-exposure prophylaxisrabiesrabies monoclonal antibodies

Identifiers

PMID42506672
PMCPMC13417358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.